Symptoms of posttraumatic stress in Australian women with ovarian cancer

被引:31
作者
Shand, Lyndel K. [1 ,2 ]
Brooker, Joanne E. [2 ,3 ]
Burney, Sue [2 ,4 ]
Fletcher, Jane [2 ]
Ricciardelli, Lina A. [1 ]
机构
[1] Deakin Univ, Sch Psychol, Burwood, Vic, Australia
[2] Cabrini Hlth, Cabrini Monash Psychooncol, Malvern, Vic 3144, Australia
[3] Monash Univ, Monash Hlth, Sch Clin Sci, Dept Psychiat, Melbourne, Vic 3004, Australia
[4] Monash Univ, Sch Psychol Sci, Melbourne, Vic 3004, Australia
关键词
ovarian cancer; cancer; oncology; PTSD; depression; anxiety; DISORDER FOLLOWING CANCER; LONG-TERM ADJUSTMENT; BREAST-CANCER; NECK-CANCER; SURVIVORS; GROWTH; TRAUMA; LIFE; PREVALENCE; INVENTORY;
D O I
10.1002/pon.3627
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe aim of the study was to assess the prevalence and nature of symptoms of posttraumatic stress disorder (PTSD) in women with ovarian cancer. A further aim was to examine the demographic, medical and psychosocial factors associated with PTSD symptoms. MethodOne hundred and eight women with ovarian cancer were assessed for PTSD, quality of life, depression, anxiety, posttraumatic growth, optimism, coping and social support. ResultsClinically significant symptoms were experienced by 9.25% of participants for PTSD, 5.6% for depression and 13.9% for anxiety. Poorer quality of life was associated with total PTSD symptoms, and avoidance and intrusive symptoms. Depression was associated with avoidance and intrusive symptoms. Anxiety was associated with total, avoidance, intrusive and hyperarousal symptoms. Finally, coping by substance use/self-blame was associated with total, avoidance and hyperarousal PTSD symptoms. ConclusionsLevels of PTSD in women with ovarian cancer were equivalent to that of the general population. Poorer quality of life, depression, anxiety and maladaptive coping, characterised by avoidance, substance use and self-blame, were associated with increased symptoms of PTSD. Copyright (c) 2014 John Wiley & Sons, Ltd.
引用
收藏
页码:190 / 196
页数:7
相关论文
共 42 条
[1]   Cognitive effects of standard-dose chemotherapy in patients with cancer [J].
Ahles, TA ;
Saykin, A .
CANCER INVESTIGATION, 2001, 19 (08) :812-820
[2]  
[Anonymous], 1993, 9 ANN CONV INT SOC T
[3]  
[Anonymous], 2013, DSM 5 DIAGN STAT MAN
[4]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]  
Australian Institute of Health and Welfare & Australasian Association of Cancer Registeries, 2012, CANC AUSTR OV 2012
[6]   Intrusive memories and depression in cancer patients [J].
Brewin, CR ;
Watson, M ;
McCarthy, S ;
Hyman, P ;
Dayson, D .
BEHAVIOUR RESEARCH AND THERAPY, 1998, 36 (12) :1131-1142
[7]  
Cancer Research UK, OV CANC MORT STAT 20
[8]   You want to measure coping but your protocol's too long: Consider the brief COPE [J].
Carver, CS .
INTERNATIONAL JOURNAL OF BEHAVIORAL MEDICINE, 1997, 4 (01) :92-100
[9]   THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE [J].
CELLA, DF ;
TULSKY, DS ;
GRAY, G ;
SARAFIAN, B ;
LINN, E ;
BONOMI, A ;
SILBERMAN, M ;
YELLEN, SB ;
WINICOUR, P ;
BRANNON, J ;
ECKBERG, K ;
LLOYD, S ;
PURL, S ;
BLENDOWSKI, C ;
GOODMAN, M ;
BARNICLE, M ;
STEWART, I ;
MCHALE, M ;
BONOMI, P ;
KAPLAN, E ;
TAYLOR, S ;
THOMAS, CR ;
HARRIS, J .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) :570-579
[10]  
Cordova Matthew J, 2003, Semin Clin Neuropsychiatry, V8, P286